Invention Grant
US09248119B2 Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
有权
黄嘌呤氧化还原酶抑制剂或黄嘌呤氧化酶抑制剂的调释剂型
- Patent Title: Modified release dosage forms of xanthine oxidoreductase inhibitor or xanthine oxidase inhibitors
- Patent Title (中): 黄嘌呤氧化还原酶抑制剂或黄嘌呤氧化酶抑制剂的调释剂型
-
Application No.: US13160572Application Date: 2011-06-15
-
Publication No.: US09248119B2Publication Date: 2016-02-02
- Inventor: Rajneesh Taneja , Vijay Gupte , Majid Vakilynejad
- Applicant: Rajneesh Taneja , Vijay Gupte , Majid Vakilynejad
- Applicant Address: US IL Deerfield
- Assignee: Takeda Pharmaceuticals U.S.A., Inc.
- Current Assignee: Takeda Pharmaceuticals U.S.A., Inc.
- Current Assignee Address: US IL Deerfield
- Agency: Foley & Lardner LLP
- Main IPC: A61K9/58
- IPC: A61K9/58 ; A61K31/426 ; A61K9/00 ; A61K9/20 ; A61K9/24 ; A61K9/50
Abstract:
The present disclosure relates to novel dosage forms of xanthine oxidoreductase inhibitors.
Public/Granted literature
- US20110311620A1 NOVEL MODIFIED RELEASE DOSAGE FORMS OF XANTHINE OXIDOREDUCTASE INHIBITOR OR XANTHINE OXIDASE INHIBITORS Public/Granted day:2011-12-22
Information query
